drugset / Trial / NCT01133080
Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Double - Blind, Randomized, single centered study. The purpose of this study is to assess the feasibility of minocycline vs. placebo, added to atypical antipsychotic medications, for positive symptoms in adults suffering from schizophrenia.
Timeline
- Start
- 2010-06
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 400 mg | Oral |